Comparing Biologic Drugs to Prevent Crohn's Return After Surgery
Treatments studied
Part of Digestive system clinical trials.
This trial compares different biologic medications to see which best prevents Crohn's disease from coming back after intestinal surgery. It may help you if you have had surgery for Crohn's and are starting a biologic drug soon after.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have Crohn's disease, confirmed by your doctor using standard tests.
- You had surgery to remove a part of your intestine because of Crohn's disease.
- You started a biologic medicine within 6 weeks after your surgery.
- You stayed on that biologic medicine for at least 3 to 6 months.
- You had a colonoscopy within 6 to 12 months after surgery to check for signs of Crohn's coming back.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if checking a stool marker (fecal calprotectin) early after surgery can guide treatment with ustekinumab to prevent Crohn's disease from coming back. It's for people who had certain bowel surgery and have at least one risk factor for recurrence.
This study tests a new oral treatment called EXL01 to see if it can prevent Crohn's disease from coming back after surgery to remove part of the small and large intestine. It may be an option if you are not planning to use strong immune-suppressing drugs (except anti-TNF) in the next 6 months.
This study tracks how well a medication called guselkumab works for people with moderate to severe Crohn's disease who have had surgery to remove part of their intestines. Researchers want to see if this treatment helps prevent the disease from coming back.
This study compares two ways to choose biologic (targeted) medicines after Crohn’s surgery to help stop Crohn’s from coming back in the bowel. It may help you avoid or delay repeat inflammation by adjusting treatment based on endoscopy findings.
This study looks at how well different biologic medications work for people with moderate to severe ulcerative colitis or Crohn's disease after one year of treatment. The goal is to see which treatment helps the gut heal best.
This study follows patients with Crohn's disease or ulcerative colitis to see how their intestine heals after surgery. It looks for signs that can predict whether inflammation will return or complications will happen.
Hear when a new Inflamatory Bowel Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.